SFI
DAWN

Susquehanna Fundamental Investments’s Day One Biopharmaceuticals DAWN Stock Holding History

Susquehanna Fundamental Investments’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-138,420
Closed -$976K – 596
2025
Q3 		$976K Sell
138,420
-124,893
-47% -$859K 0.04% 334
2025
Q2 		$1.71M Sell
263,313
-59,562
-18% -$410K 0.05% 365
2025
Q1 		$2.56M Buy
+322,875
New +$3.48M 0.04% 470

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Fundamental Investments's DAWN Position: Q4 2025 in Review

Susquehanna Fundamental Investments sold out of Day One Biopharmaceuticals (DAWN) in Q4 2025, closing a stake of 138,420 shares — an estimated $976K sold.

Susquehanna Fundamental Investments first reported a position in DAWN in Q1 2025 and held it in 3 quarters. The position peaked at $2.56M in Q1 2025. 183 funds tracked by Wall St. Rank hold DAWN as of Q4 2025.

  • Susquehanna Fundamental Investments reported no remaining Day One Biopharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 138,420 Day One Biopharmaceuticals shares in Q4 2025, an estimated $976K.
  • Susquehanna Fundamental Investments first reported a position in Day One Biopharmaceuticals in Q1 2025 and held it in 3 quarters.
  • Susquehanna Fundamental Investments's Day One Biopharmaceuticals position peaked at $2.56M in Q1 2025.
  • 183 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q4 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2025, filed 17 Feb 2026.